Long COVID patients seek funding for effective treatments

Five years after the COVID-19 pandemic began, around 18 million U.S. adults are estimated to suffer from long COVID. Patients continue to seek effective treatments, but no approved therapies exist yet. New patients are still emerging. Research on long COVID is progressing, with about 50 drug trials currently underway, a significant increase from previous years. Scientists are exploring various potential causes and symptoms, but translating findings into effective treatments remains a challenge. Patient advocates are now lobbying the new administration for more funding and research focus. They emphasize the need for collaboration despite political differences, as many patients still struggle to find knowledgeable care.